Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Mult Scler Relat Disord ; 18: 144-151, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29141797

RESUMO

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a relapsing neuro inflammatory disease of the central nervous system that typically presents with optic neuritis or myelitis and may cause severe disability. The diagnostic criteria have been updated and several immunosuppressive agents have been demonstrated to prevent acute exacerbations. As the disease rarely develops in a progressive course, management of acute attacks and proper prevention of exacerbations may change the long term out-come and prevent future disability. Consensus recommendations and guidelines will help the physicians to improve their practice and unify the treatment approaches in different communities. In order to develop a national consensus and recommendations for the diagnosis and management of NMOSD in Iran, a group of neurologists with long term experience in management of NMOSD were gathered to develop this consensus based on available national and international data. The primary draft was prepared and discussed to suggest the most appropriate treatment for these patients. We propose strategies for early diagnosis and treatment for prevention of relapses and minimizing consequences of attacks as a primary therapeutic goal. Attacks are currently treated with intravenous corticosteroids and, in refractory cases, with plasma exchange. All participants agreed on preventive treatment with currently available immunosuppressive agents such as azothioprin, rituximab and mycofenolate mofetil based on previous positive data in NMOSD in order to reduce attack frequency. The current consensus reviews the previous data and provides the clinicians with practical recommendations and advices for the diagnosis and management of NMOSD based on scientific data and clinical experience.


Assuntos
Neuromielite Óptica/diagnóstico , Neuromielite Óptica/terapia , Gerenciamento Clínico , Humanos , Irã (Geográfico) , Guias de Prática Clínica como Assunto
3.
BMC Neurol ; 14: 56, 2014 Mar 22.
Artigo em Inglês | MEDLINE | ID: mdl-24655543

RESUMO

BACKGROUND: Month-long daytime Ramadan fasting pose s major challenges to multiple sclerosis (MS) patients in Muslim countries. Physicians should have practical knowledge on the implications of fasting on MS. We present a summary of database searches (Cochrane Database of Systematic Reviews, PubMed) and a mini-symposium on Ramadan fasting and MS. In this symposium, we aimed to review the effect of fasting on MS and suggest practical guidelines on management. DISCUSSION: In general, fasting is possible for most stable patients. Appropriate amendment of drug regimens, careful monitoring of symptoms, as well as providing patients with available evidence on fasting and MS are important parts of management. Evidence from experimental studies suggests that calorie restriction before disease induction reduces inflammation and subsequent demyelination and attenuates disease severity. Fasting does not appear to have unfavorable effects on disease course in patients with mild disability (Expanded Disability Status Scale (EDSS) score ≤3). Most experts believed that during fasting (especially in summer), some MS symptoms (fatigue, fatigue perception, dizziness, spasticity, cognitive problems, weakness, vision, balance, gait) might worsen but return to normal levels during feasting. There was a general consensus that fasting is not safe for patients: on high doses of anti-convulsants, anti-spastics, and corticosteroids; with coagulopathy or active disease; during attacks; with EDSS score ≥7. SUMMARY: These data suggest that MS patients should have tailored care. Fasting in MS patients is a challenge that is directly associated with the spiritual belief of the patient.


Assuntos
Jejum/efeitos adversos , Jejum/fisiologia , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/epidemiologia , Animais , Progressão da Doença , Fadiga/diagnóstico , Fadiga/epidemiologia , Fadiga/fisiopatologia , Humanos , Esclerose Múltipla/fisiopatologia
4.
Ophthalmic Plast Reconstr Surg ; 26(6): 448-9, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20736876

RESUMO

PURPOSE: To describe a technique for excisional biopsy of eyelid papillomatous lesions using a radiofrequency (RF) unit. METHOD: In this prospective, interventional case series, 64 patients with eyelid papillomatous lesions underwent excisional biopsy using an RF unit. RESULTS: The upper eyelid was involved in 34.5% and the lower eyelid was involved in 62.5% of cases, with 3% having lesions on both eyelids. Surgery was performed with no intraoperative or postoperative bleeding, avoiding wound sutures and bandage and with very good cosmetic results. On histopathologic examination, 72% of these lesions were squamous papilloma. Reoperation was needed in 2 patients. Over-resection and notching of the eyelid margin happened in one patient but improved 3 months after surgery. CONCLUSION: Use of an RF unit for excisional biopsy of eyelid papillomatous lesions is a safe and effective method.


Assuntos
Ablação por Cateter , Neoplasias Palpebrais/cirurgia , Papiloma/cirurgia , Adulto , Idoso , Biópsia , Neoplasias Palpebrais/patologia , Feminino , Humanos , Complicações Intraoperatórias , Masculino , Pessoa de Meia-Idade , Papiloma/patologia , Complicações Pós-Operatórias , Estudos Prospectivos , Reoperação , Cicatrização , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...